New RSV Vaccine May Prevent Illness in Infants, Seniors
THURSDAY, April 6, 2023 (HealthDay News) — An RSV vaccine developed by Pfizer provides safe and effective protection in both seniors and newborns, clinical trial results show. The vaccine is 86% effective in protecting older adults against RSV infections severe enough to cause three or more symptoms, according to findingsContinue Reading










